Loading...
Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
BACKGROUND: Irritable bowel syndrome with diarrhea (IBS-D) has limited options for treatment currently, including mainly anti-motility medications, antispasmodics, and antidepressants. This review discusses the properties of a new drug, eluxadoline, a gut-targeting mu- and kappa-opioid receptor agon...
Na minha lista:
| Udgivet i: | Clin Exp Gastroenterol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624596/ https://ncbi.nlm.nih.gov/pubmed/28989282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S123621 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|